Skip to content

Effects of Mild Hypobaric Hypoxia on Sleep and Post-sleep Performance

Investigation to Determine the Effects of Mild Hypobaric Hypoxia on Sleep and Post-Sleep Neurobehavioral Performance

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00498563
Enrollment
34
Registered
2007-07-10
Start date
2006-10-31
Completion date
2007-08-31
Last updated
2015-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Altitude, Environmental Sleep Disorder, Hypoxia

Keywords

high altitude, sleep, altitude illness, neurobehavioral manifestations, psychomotor performance, mood states

Brief summary

Hypobaric hypoxia (decreased oxygen supply to body tissues due to low atmospheric pressure) caused by exposure to high altitude disrupts sleep. Sleep deprivation is associated with degraded post-sleep performance of neurobehavioral tasks. The lowest altitude at which sleep and/or post-sleep performance are affected is not known. The study hypothesis is that sleep and/or post-sleep performance of neurobehavioral tasks will occur due to hypobaric hypoxia at altitudes of 8,000 or less.

Interventions

PROCEDUREaltitude exposure in hypobaric chamber

Sponsors

The Boeing Company
CollaboratorINDUSTRY
Oklahoma State University Center for Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE

Eligibility

Sex/Gender
MALE
Age
30 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy * age 30 to 60 years

Exclusion criteria

* sleep disorders or abnormal sleep patterns * mood or psychiatric disorders including claustrophobia * altitude exposure above 5,000 ft in the previous 2 months * born or raised at terrestrial altitude 5,000 ft or greater * conditions that would disqualify for FAA Medical Certificate * acute medical conditions

Design outcomes

Primary

MeasureTime frame
Quality and quantity of sleep measured by actigraphy and polysomnography Neurobehavioral performance measured by Psychomotor Vigilance Test (PVT) and Automated Neurophysiologic Assessment Metrics Battery (ANAM)7 hours; 4 hours

Secondary

MeasureTime frame
Mood State measured by Profile of Mood States (POMS) Symptoms of altitude illness measured by Environmental Symptoms Questionnaire (ESQ IV) and Lake Louise Symptom Scores (LLS)20 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026